HCA Healthcare, Inc. (HCA)
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
- Ticker
- HCA
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Market cap
- $105.69B
- 52-week range
- $353.99 - $556.52
Valuation
- Share price
- $476.35 (close of Nov 18, 2026)
- P/E (TTM)
- 16.38x
- Price to book
- -22.98x
- Price to free cash flow
- 17.69x
- Enterprise value
- $157.21B
- Book value per share
- $-21.81
Price performance
| Period | Change |
|---|---|
| 1 day | -4.96% |
| 5 days | -5.87% |
| 1 month | +3.82% |
| 3 months | +15.69% |
| 6 months | +12.67% |
| Year to date | +2.03% |
| 1 year | -0.37% |
| 3 years | +93.34% |
| 5 years | +95.83% |
| 10 years | +558.03% |
| All time | +1,435.62% |
Short interest
- As of
- Oct 30, 2026
- Short % of float
- 3.60%
- Shares short
- 4.80M
- Days to cover
- 3.31
- Change since prior report
- -2.14%
- Source
- FINRA consolidated short interest
Members of Congress who disclosed HCA trades
Jared Moskowitz · Lisa McClain · Val Hoyle · Alan Armstrong · Julie Johnson · Robert Bresnahan
Super investors holding HCA
First Eagle Investment (First Eagle Investment Management, LLC) · Ray Dalio (Bridgewater Associates) · Bill Nygren (Harris Associates LP) · First Pacific Advisors (First Pacific Advisors, LP) · Ken Griffin (Citadel) · Richard Pzena (Pzena Investment Management) · Glenn Greenberg (Brave Warrior Advisors, LLC) · Lee Ainslie (Maverick Capital LTD)
Profitability and growth
- Return on invested capital
- 21.84%*
- Return on assets
- 11.17%
- Return on capital employed
- 27.23%*
- Net margin
- 8.97%
- EBITDA margin
- 19.32%
- Revenue growth
- 7.08%
- Net income growth
- 17.78%
- Free cash flow growth
- 36.41%
* Estimated EBIT: pre-tax income + net interest. This company reports no operating income line.
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 5.65%
- Current ratio
- 0.82x
- Net debt to EBITDA
- 3.24x
Latest reported year
- Period end
- Dec 31, 2025
- Fiscal year
- 2025
- Revenue
- $75.60B
- EBITDA
- $14.61B
- Net income
- $6.78B
- Earnings per share
- $28.70
- Interest expense
- $2.25B
- Shares outstanding
- 236.41M
Income statement by year
| Period end | Revenue | Net income | EPS |
|---|---|---|---|
| 2025-12-31 | $75.60B | $6.78B | $28.70 |
| 2024-12-31 | $70.60B | $5.76B | $22.27 |
| 2023-12-31 | $64.97B | $5.24B | $19.25 |
| 2022-12-31 | $60.23B | $5.64B | $19.43 |
| 2021-12-31 | $58.75B | $6.96B | $21.52 |
| 2020-12-31 | $51.53B | $3.75B | $11.10 |
| 2019-12-31 | $51.34B | $3.50B | $10.27 |
| 2018-12-31 | $46.68B | $3.79B | $10.90 |
| 2017-12-31 | $43.61B | $2.22B | $6.12 |
| 2016-12-31 | $41.49B | $2.89B | $7.53 |
Margins and returns by year
| Period end | Net margin | Return on equity | Return on capital |
|---|---|---|---|
| 2025-12-31 | 8.97% | - | 21.84%* |
| 2024-12-31 | 8.16% | - | 19.04%* |
| 2023-12-31 | 8.07% | - | 18.71%* |
| 2022-12-31 | 9.37% | - | 21.37%* |
| 2021-12-31 | 11.84% | - | 23.85%* |
| 2020-12-31 | 7.28% | 129.81% | 16.33%* |
| 2019-12-31 | 6.83% | - | 16.78%* |
| 2018-12-31 | 8.11% | - | 20.55%* |
| 2017-12-31 | 5.08% | - | 15.80%* |
| 2016-12-31 | 6.97% | - | 19.96%* |
* Estimated EBIT: pre-tax income + net interest. This company reports no operating income line.
Cash and debt by year
| Period end | Cash | Debt |
|---|---|---|
| 2025-12-31 | $1.04B | $41.60B |
| 2024-12-31 | $1.93B | $38.33B |
| 2023-12-31 | $935.00M | $37.17B |
| 2022-12-31 | $908.00M | $37.71B |
| 2021-12-31 | $1.45B | $34.34B |
| 2020-12-31 | $1.91B | $30.80B |
| 2019-12-31 | $768.00M | $33.58B |
| 2018-12-31 | $549.00M | $32.03B |
| 2017-12-31 | $786.00M | $32.86B |
| 2016-12-31 | $695.00M | $31.16B |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|---|---|
| 2025-12-31 | $7.69B | $401.00M |
| 2024-12-31 | $5.64B | $360.00M |
| 2023-12-31 | $4.69B | $262.00M |
| 2022-12-31 | $4.13B | $341.00M |
| 2021-12-31 | $5.38B | $440.00M |
| 2020-12-31 | $6.40B | $362.00M |
| 2019-12-31 | $3.44B | $347.00M |
| 2018-12-31 | $3.19B | $268.00M |
| 2017-12-31 | $2.41B | $270.00M |
| 2016-12-31 | $2.89B | $251.00M |
Dividend history
- Most recent payment
- Sep 16, 2026
- Paid in the last twelve months
- $3.06
| Payment date | Dividend per share |
|---|---|
| 2026-09-16 | $0.78 |
| 2026-06-16 | $0.78 |
| 2026-03-17 | $0.78 |
| 2025-12-15 | $0.72 |
| 2025-09-16 | $0.72 |
| 2025-06-16 | $0.72 |
| 2025-03-17 | $0.72 |
| 2024-12-13 | $0.66 |
Investor relations
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|---|---|
| 2026-10-27 | Sep 2026 | $6.74 |
| 2026-07-24 | Jun 2026 | $7.57 |
| 2026-04-24 | Mar 2026 | $7.17 |
| 2026-01-27 | Dec 2025 | $7.36 |
| 2025-10-24 | Sep 2025 | $5.65 |
| 2025-07-25 | Jun 2025 | $6.19 |
| 2025-04-25 | Mar 2025 | $5.77 |
| 2025-01-24 | Dec 2024 | $5.97 |
Filings and sources
- Company website
- hcahealthcare.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
DaVita Inc. (DVA) · Universal Health Services Inc (UHS) · HealthEquity, Inc. (HQY) · Veeva Systems Inc (VEEV) · Abbott Laboratories (ABT) · Molina Healthcare, Inc. (MOH) · Medtronic plc (MDT) · Centene Corp (CNC)
Understanding these figures
Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades